Medpace Holdings (MEDP) Revenue Growth (3y) (2018 - 2026)
Medpace Holdings (MEDP) Revenue Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 3.92% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 1.95% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 42.27% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 2.24% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 5.42% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 8.84% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -0.48% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 1.51% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 7.14% |
| 10 | Medpace Holdings | 17.20 Bn | 16.70 Bn | 201.64 Mn | 15.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.35% |
| Mar 31, 2026 | 17.64% |
| Dec 31, 2025 | 21.59% |
| Sep 30, 2025 | 19.81% |
| Jun 30, 2025 | 19.76% |
| Mar 31, 2025 | 19.06% |
| Dec 31, 2024 | 20.26% |
| Sep 30, 2024 | 21.74% |
| Jun 30, 2024 | 23.81% |
| Mar 31, 2024 | 25.27% |
| Dec 31, 2023 | 24.27% |
| Sep 30, 2023 | 28.82% |
| Jun 30, 2023 | 31.00% |
| Mar 31, 2023 | 23.42% |
| Dec 31, 2022 | 19.68% |
| Sep 30, 2022 | 21.07% |
| Jun 30, 2022 | 17.94% |
| Mar 31, 2022 | 18.13% |
| Dec 31, 2021 | 17.11% |
| Sep 30, 2021 | 18.14% |